|
Inpatient mortality, n(%)
|
Mortality in 1 year, n(%)
|
ICU,
n(%)
|
Dialysis, n(%)
|
Dialysis, n(%)
|
Length of hospital stay**,
Mean (SD)
|
Length of hospital stay**,
Mean (SD)
|
Length of hospital stay**,
Mean (SD)
|
Flares in 1 year, n(%)
|
Flares in 1 year, n(%)
|
Readmission in 1 year, n(%)
|
Readmission in 1 year, n(%)
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|
Note: **Poisson regression model was fit and associated risk is
expressed as incidence rate ratio (IRR) with corresponding 95%CI.
*Unadjusted OR is calculated with respect to “no viral reactivation”,
₳Unadjusted OR is calculated with respect to “no HHV6
Reactivation”, ₵Unadjusted OR is calculated with
respect to “no CMV Reactivation”, ₱Unadjusted OR is
calculated with respect to “no EBV Reactivation”, Unadjusted OR is
calculated with respect to “≤ 2 Herpesvirus reactivations”.
|